MMP2 and lip and oral cavity carcinoma: However, treatment of the oral cancer cells with ERK inhibitor resulted in no significant changes in MMP-2 secretion (data not shown), indicating that signaling pathways other than ERK1/2 might be involved in SHP2-mediated MMP-2 secretion.